Status:
UNKNOWN
Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage
Lead Sponsor:
Aswan University Hospital
Conditions:
Abortion, Missed
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
This study compares the success rate of Adjuvant isonicotinic acid hydrazide and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy among women with one or more ...
Detailed Description
In the past, the role of laminaria and prostaglandins in cervical dilatation and reducing intraoperative complications of cervical dilatation have been proven . Misoprostol is a synthetic analogue of ...
Eligibility Criteria
Inclusion
- Gestational age less than 70 days gestation (\<10 wks).
- Hemoglobin \>10 g/dL.
- BMI between 18.5 kg/m2 and 30 kg/m2.
- Missed abortion
- previous one or more cesarean deliveries
Exclusion
- Molar pregnancy
- Fibroid uterus.
- Uterine anomalies.
- Coagulopathy
- Medical disorder that contraindicate induction of abortion (e.g. heart failure).
- Previous attempts for induction of abortion in the current pregnancy.
- Allergy to misoprostol or INH.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04499976
Start Date
September 1 2020
End Date
June 30 2021
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528